Mental Disorders

286 trials 120 recruiting

Filter these 286 trials by phase, country and sponsor.

Open in Search →

Assessment of microglial activation in patients with schizophrenia stratified for C4 complement by PET using [18F]DPA-714 Recruiting

2023-504181-38-00 pathology studied is schizophrenia 10 2025-11-17
Silexan® in mild to moderate major depressive disorder Recruiting

2025-521744-37-00 Mild to moderate major depressive disorder 5 2025-11-17
Psilocybin's effects on anhedonia Recruiting

2024-519265-22-00 Major Depressive Disorder 3 2025-11-12
A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder Recruiting

2024-520165-32-00 BP-I mania or mania with mixed features 5 2025-11-04
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease. Recruiting

2025-520613-31-00 Agitation Associated with Alzheimer’s Disease 5 2025-10-31
A Phase 3 Trial to Assess CYB003 in Major Depressive Disorder Recruiting

2024-519270-40-00 Major Depressive Disorder 5 2025-10-30
Sleeping through Menopause Recruiting

2024-512071-12-00 Insomnia 6 2025-10-29
A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease Recruiting

2025-520747-32-00 Mild to moderate Alzheimer’s Disease 5 2025-10-29
Study to assess the maintenance of effect of NBI-1065845 as an adjunctive treatment in participants with Major Depressive Disorder (MDD) Recruiting

2025-520541-72-00 Major Depressive Disorder 5 2025-10-22
Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519420-25-00 Major Depressive Disorder 5 2025-10-22
Treatment of anaemia after caesarean with intravenous versus oral iron and postpartum depression: a multicentric randomized open-labelled co… Recruiting

2023-503283-17-00 Women who delivered by caesarean and have a moderate po 6 2025-10-22
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder Recruiting

2024-520333-68-00 Major Depressive Disorder 5 2025-09-26
Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519418-29-00 Major Depressive Disorder 5 2025-09-19
Study to assess the efficacy and safety of adjunctive NBI-1065845 in adults with Major Depressive Disorder (MDD) Recruiting

2024-519421-37-00 Major Depressive Disorder 5 2025-08-28
Melatonin versus quetiapine in adolescents (MEL-QUE-A) Recruiting

2024-519597-39-00 Psychiatric disorder (ICD-10 F20-F69, F84, F90-F95) and 10 2025-08-18
CO2 challenge study of NTX-1955 in healthy participants Recruiting

2025-522281-68-00 Generalized Anxiety Disorder (GAD) 3 2025-08-08
A study to assess the efficacy and safety of ITI-1284 as monotherapy treatment in patients with Generalized Anxiety Disorder Recruiting

2024-516684-82-00 Generalized Anxiety Disorder 4 2025-07-21
A double-blind, randomized, controlled trial on the effect of PEX010 for prolonged grief disorder Recruiting

2024-518218-24-00 Prolonged grief disorder 4 2025-07-17
Evaluation of p-glycoprotein alterations in treatment-resistant depression: a [18F]MC225 PET study Recruiting

2023-508303-20-01 depression 4 2025-07-14
A study to assess the efficacy and safety of ITI-1284 in the treatment of Psychosis Associated with Alzheimer's Disease Recruiting

2024-513035-25-00 Psychosis associated with Alzheimer’s Disease 4 2025-07-11
The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder (MDD): a translational … Recruiting

2024-512559-20-01 Major Depressive Disorder (MDD) 5 2025-07-10
Treatment with acetylcholine esterase inhibitors in anorexia nervosa : a multicenter double-blind randomised controlled trial versus placebo Recruiting

2024-511681-37-00 Anorexia nervosa 4 2025-07-02
Exploring GLP-1 Receptor Agonist Treatment for Adolescents with Antipsychotic-Related Obesity: The GOAL Study Recruiting

2024-517471-21-02 Adipositas 6 2025-06-24
A trial to investigate the effects of Cannabidiol plus Naltrexone on alcohol craving in patients with alcohol dependence Recruiting

2024-518164-12-00 Alcohol dependence 4 2025-06-16